Hilton Grand Vacations to buy Bluegreen Vacations for a more-than 100% premium
Hilton Grand Vacations Inc. (HGV) announced Monday an agreement to buy Bluegreen Vacations Inc. (BVH) in cash deal valued at $1.5 billion, including debt. Under terms of the deal, Hilton Grand Vacations (HGV) will pay $75 in cash for each Bluegreen share outstanding, which represents a 111.1% premium over Friday's stock closing price of $35.52, and implies a market capitalization for Bluegreen of about $1.28 billion. Bluegreen's stock rocketed 105.4% in the premarket, while HGV shares sank 8.6%. HGV said the deal, which is expected to close during the first half of 2024, will generate about $100 million in synergies, and will expand HGV's membership base to more than 740,000 from more than 525,000. Separately, HGV announced the signing of an exclusive 10-year marketing agreement with outdoor recreation products retailer Bass Pro Shops, as Bluegreen is the official vacation ownership partner of Bass Pro Shops. Bluegreen's stock has gained 0.4% over the past three months and HGV shares have dropped 16.2%, while the S&P 500 has slipped 2.7%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-06-23 0850ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks